断层合成十年后的筛查乳腺X线摄影:大型医疗系统中合成乳腺X线摄影使用情况差异很大
该回顾性研究分析了2023年2月26日至3月12日9家医院61台乳腺X线摄影系统的连续筛查检查,共6849次检查、13484侧乳房,评估合成乳腺X线摄影(SM)的使用程度及其对平均腺体剂量(AGD)的影响。结果显示仅3家医院优先使用SM(占乳房81.3%-93.5%),SM可使AGD降低36.5%。
要点
- 在平均乳房厚度约6 cm时,仅3D模式每侧乳房平均AGD为4-6.1 mGy,2D/3D联合模式为5.5-9.94 mGy,仅2D模式为0.29-5.32 mGy。
- 无2D采集的3D模式与有2D采集的3D+2D模式平均AGD比值分别为0.589(95%CI 0.561-0.619)、0.625(0.563-0.702)和0.588(0.508-0.696)。
- 同一大型医疗系统内9家医院中仅3家优先使用SM,提示各中心筛查协议存在差异。
核心结论
- SM可降低平均腺体剂量(AGD降低36.5%),但同一大型医疗系统内9家医院中仅3家采用该技术;需要审查重复筛查乳腺X线摄影检查,并在满足临床要求时采用SM以优化患者剂量。
研究设计与样本
- 回顾性研究,分析大型但不完全整合的医疗系统中9家医院61台乳腺X线摄影系统在2023年2月26日至3月12日期间的连续筛查检查,共6849次检查(13484侧乳房),数据包括2D采集次数、3D视图、乳房厚度和AGD,使用R统计软件(版本4.3.2)进行统计分析。
诊断标准与关键数值
- 13484侧乳房中99.99%(13482/13484)接受了3D视图,70.15%(9459/13484)接受了2D采集。
- 平均乳房厚度约6 cm时,每侧乳房平均AGD:仅2D为0.29-5.32 mGy,仅3D为4-6.1 mGy,2D/3D联合为5.5-9.94 mGy。
- 对于平均乳房,无2D采集的3D模式平均AGD与有2D采集的3D+2D模式平均AGD比值分别为0.589(95%CI 0.561-0.619)、0.625(95%CI 0.563-0.702)和0.588(95%CI 0.508-0.696)。
- SM使AGD降低36.5%。
临床应用与阅片要点
- 作者建议审查重复筛查乳腺X线摄影检查,并在满足临床要求时采用SM以优化患者剂量。
- 作者认为乳腺中心应考虑审查其成像协议,以优化接受年度筛查乳腺X线摄影并使用SM的患者的辐射剂量。
局限性
- 本研究为回顾性研究。
- 研究在一个大型但不完全整合的医疗系统中进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Digital breast tomosynthesis (DBT) with 2-dimensional acquisition (2D) was approved in 2011 for breast cancer screening in the United States. To reduce radiation dose to breasts, synthetic mammography (SM) was developed and approved to replace 2D with combo DBT in 2013. This retrospective study of screening practices in a large, incompletely integrated health system, assesses extent of SM utilization, and examines its impact on average glandular dose (AGD).
METHODS: Consecutive screening exams on 61 mammography systems at 9 hospitals from February 26 to March 12, 2023, were examined. Data collection included patient exams and radiation exposure. Comprehensive analysis included number of 2D acquisitions, 3-dimensional (3D) views, breast thickness, and AGD. Comparative assessments were made across the health system cohort and individual hospitals. Statistical analysis was performed using the R statistical software (version 4.3.2).
RESULTS: This study included 6849 screening exams on 13 484 breasts (thickness, 5.96 ± 1.47 cm) that received 3D views (13 482/13 484, or 99.99%) and 2D acquisitions (9459/13 484, or 70.15%). For average breast thickness (about 6 cm), mean AGD per breast was 0.29-5.32 mGy (2D only), 4-6.1 mGy (3D only), and 5.5-9.94 mGy (2D/3D). Three hospitals preferentially used SM (81.3%-93.5% of breasts). For an average breast, the ratio of mean AGD(3D) without 2D acquisitions to mean AGD(3D + 2D) with 2D acquisitions was 0.589 (95% CI: 0.561-0.619), 0.625 (0.563-0.702), and 0.588 (0.508-0.696), respectively.
CONCLUSIONS: SM reduces AGD. There is a need to review recurring screening mammographic exams, and optimize patient doses by adopting SM, where it meets the clinic's requirements.
ADVANCES IN KNOWLEDGE: SM reduces AGD by 36.5%, but only 3 of 9 hospitals within the same large health system have adopted this technology. Breast centres should consider reviewing their imaging protocols to optimize radiation doses for patients undergoing annual screening mammography with SM.
引用
- Li X, Giess CS, Chikarmane SA, et al. Screening mammography a decade post-tomosynthesis: varied utilization of synthetic mammography across a large health system. Br J Radiol. 2025. PMID: 40795810. doi:10.1093/bjr/tqaf137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。